Nakamura et al. revealed that the osteoclast-derived chemotactic cytokine C-C motif chemokine 22 (CCL22) activates the AKT pathway in lung cancer cells via the C-C chemokine receptor type 4 (CCR4) and, thus, promotes bone metastasis. Here, CCL22 is linked to lung carcinoma.